GO:0001676 long-chain fatty acid metabolic process: Energy Homeostasis, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001676 describes the chemical reactions and pathways involving fatty acids with aliphatic tails of 13 to 22 carbons, a central hub of cellular energy metabolism and membrane biogenesis.
• Long-chain fatty acids (LCFAs) are the preferred oxidative substrate for the healthy heart, and their metabolic flux is tightly coupled to cardiac contractile function.
• LCFA metabolism is not merely catabolic: intermediates such as acyl-CoAs act as signaling molecules that regulate transcription factors, ion channels, and insulin sensitivity.
• Excessive LCFA supply without adequate storage or oxidation drives lipotoxicity, a process mitigated by triglyceride synthesis and lipid droplet formation.
• Mitochondrial dynamics, particularly fission, reprogram LCFA metabolism in cancer cells and are linked to tumor growth and survival.
• Key genes in this process include ACSL1, CPT1A, ACADVL, HADHA, and SCD1, which are frequent targets for CRISPR knockout, knock-in, and point-mutation studies.
Description
Long-chain fatty acid metabolic process (GO:0001676) encompasses the biochemical reactions and pathways that convert fatty acids with 13 to 22 carbon atoms into energy, membrane lipids, and signaling molecules. This process is fundamental to cellular bioenergetics, as long-chain fatty acids (LCFAs) are the primary fuel for tissues such as the heart and skeletal muscle, and they serve as precursors for complex lipids including phospholipids and sphingolipids. Dysregulation of LCFA metabolism is implicated in a broad spectrum of human diseases, from cardiomyopathy and insulin resistance to cancer and neurodegeneration [1, 7]. Researchers study GO:0001676 to understand how cells balance fatty acid uptake, activation, mitochondrial import, beta-oxidation, and storage. The pathway intersects with transcriptional regulation by nuclear receptors, post-translational modification of enzymes, and mitochondrial dynamics [1, 7]. Because LCFAs can be toxic when they accumulate in non-adipose tissues, the metabolic process is also a key determinant of cell survival and death. Advances in CRISPR gene editing have made it possible to systematically dissect the contribution of individual genes within this pathway. By generating knockout, point-mutation, knock-in, and overexpression cell models, researchers can assign causal roles to enzymes, transporters, and regulatory proteins involved in long-chain fatty acid metabolism. This article integrates the QuickGO definition with verified literature to provide a research-grade overview of GO:0001676, its key genes, regulatory mechanisms, disease links, and experimental strategies.
long-chain fatty acid metabolic process At A Glance
| GO ID | GO:0001676 |
|---|---|
| GO term | long-chain fatty acid metabolic process |
| Ontology | biological_process |
| Synonym | long-chain fatty acid metabolism |
| Definition | The chemical reactions and pathways involving a long-chain fatty acid. A long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons. |
| Major function | Energy production via beta-oxidation, membrane lipid synthesis, and lipid signaling |
| Key substrates | Long-chain fatty acids (C13-C22), acyl-CoA, acetyl-CoA |
| Cellular locations | Cytosol, mitochondria, peroxisomes, endoplasmic reticulum |
| Related processes | Fatty acid beta-oxidation, triglyceride biosynthesis, phospholipid metabolism |
What Is GO:0001676?
GO:0001676, long-chain fatty acid metabolic process, is defined by QuickGO as the chemical reactions and pathways involving a long-chain fatty acid, where a long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons. In practice, this includes the activation of LCFAs to acyl-CoA thioesters, their transport into mitochondria or peroxisomes, their oxidation to acetyl-CoA, their desaturation and elongation, and their incorporation into complex lipids such as triglycerides and phospholipids [1, 5].
Why Is long-chain fatty acid metabolic process Important in Cell Biology?
GO:0001676 is essential because long-chain fatty acids are the most abundant dietary and stored lipids, and their metabolism provides the majority of ATP for the heart and resting skeletal muscle. Beyond energy, LCFAs and their derivatives act as ligands for nuclear receptors and as substrates for membrane lipid synthesis, thereby influencing gene expression, insulin sensitivity, and inflammation. Defects in LCFA oxidation cause severe metabolic disorders, and altered LCFA metabolism is a hallmark of cancer, cardiac disease, and obesity-related pathologies [2, 7].
• LCFA oxidation supplies up to 70% of ATP in the healthy heart, making this pathway critical for cardiac function.
• Acyl-CoA intermediates regulate transcription factors such as PPARs and SREBP, linking LCFA metabolism to gene expression.
• Impaired LCFA oxidation leads to accumulation of toxic intermediates and cardiomyopathy.
• Triglyceride synthesis from LCFAs protects non-adipose tissues from lipotoxicity.
• Mitochondrial fission promotes LCFA metabolic reprogramming in hepatocellular carcinoma.
• LCFA metabolism is a source of precursors for eicosanoids and other signaling lipids.
• Triheptanoin, a medium-chain triglyceride, is used to bypass defects in long-chain fatty acid oxidation.
• The pathway is a target for drugs treating diabetes, dyslipidemia, and heart failure [1, 2].
• CRISPR screens can identify novel regulators of LCFA metabolism in cancer and metabolic disease.
What Happens During long-chain fatty acid metabolic process?
Uptake and Activation of Long-Chain Fatty Acids
In simple terms: Cells take up long-chain fatty acids from the blood and attach them to coenzyme A to make them reactive.
Long-chain fatty acids enter cells via protein-mediated transport, including CD36 and fatty acid transport proteins. Once inside, they are activated by acyl-CoA synthetases (ACSL1, ACSL3, ACSL4) to form long-chain acyl-CoA, a reaction that consumes ATP and is essential for all downstream metabolism [1, 5]. This activation step traps the fatty acid inside the cell and commits it to either oxidation or lipid synthesis.
Mitochondrial Import via the Carnitine Shuttle
In simple terms: Long-chain acyl-CoAs cannot cross the mitochondrial membrane directly; they need a shuttle system.
The carnitine palmitoyltransferase system (CPT1A, CPT2, and carnitine-acylcarnitine translocase) transports long-chain acyl-CoA into the mitochondrial matrix. CPT1A on the outer mitochondrial membrane is the rate-limiting enzyme and is inhibited by malonyl-CoA, linking LCFA oxidation to glucose availability [1, 2]. Defects in this shuttle cause severe disorders of long-chain fatty acid oxidation.
Beta-Oxidation and Energy Production
In simple terms: Inside mitochondria, long-chain fatty acids are chopped into two-carbon units that feed the Krebs cycle.
Beta-oxidation is a four-step cycle that removes two carbons per round, generating acetyl-CoA, NADH, and FADH2. Long-chain substrates require chain-shortening enzymes such as acyl-CoA dehydrogenases (ACADVL, ACADM) and trifunctional protein (HADHA/HADHB). Acetyl-CoA enters the TCA cycle and oxidative phosphorylation to produce ATP. In peroxisomes, a parallel beta-oxidation system shortens very-long-chain and branched-chain fatty acids before mitochondrial oxidation.
Desaturation and Elongation of Long-Chain Fatty Acids
In simple terms: Cells can modify long-chain fatty acids by adding double bonds or extending the carbon chain.
Stearoyl-CoA desaturase (SCD) introduces a double bond into saturated LCFAs to form monounsaturated fatty acids, which are important for membrane fluidity and lipid storage. Elongases (ELOVL family) extend the carbon chain, and desaturases (FADS1, FADS2) introduce double bonds to produce long-chain polyunsaturated fatty acids (LC-PUFAs) such as arachidonic acid and DHA. These modifications are critical for membrane function and signaling.
Storage as Triglycerides and Lipotoxicity Protection
In simple terms: When cells have more fatty acids than they can burn, they store them as triglycerides to avoid toxicity.
Excess long-chain fatty acids are esterified into triglycerides by DGAT enzymes and stored in lipid droplets. This storage protects cells from lipotoxicity, as demonstrated by the finding that triglyceride accumulation protects against fatty acid-induced lipotoxicity in non-adipose cells. The balance between oxidation and storage is regulated by nutrient availability and hormonal signals.
Key Genes Involved in GO:0001676 long-chain fatty acid metabolic process
The following genes encode enzymes, transporters, and regulatory proteins that directly participate in or control long-chain fatty acid metabolic process (GO:0001676).
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACSL1 | Activates long-chain fatty acids to acyl-CoA | Rate-limiting for oxidation and lipid synthesis; knockout reduces fatty acid oxidation |
| CPT1A | Rate-limiting enzyme for mitochondrial import of LCFA | Target for modulating cardiac and hepatic fatty acid oxidation |
| CPT2 | Inner mitochondrial membrane transferase | Defects cause CPT2 deficiency and rhabdomyolysis |
| ACADVL | Very-long-chain acyl-CoA dehydrogenase | Mutations cause VLCAD deficiency, a severe LCFA oxidation disorder |
| ACADM | Medium-chain acyl-CoA dehydrogenase | Model for beta-oxidation enzymology |
| HADHA | Trifunctional protein alpha subunit | Defects cause mitochondrial trifunctional protein deficiency |
| HADHB | Trifunctional protein beta subunit | Mutations lead to neuropathy and cardiomyopathy |
| SCD1 | Desaturates saturated LCFAs to monounsaturated | Regulates lipogenesis and insulin sensitivity |
| FADS1 | Delta-5 desaturase for LC-PUFA synthesis | Associated with inflammatory and metabolic traits |
| FADS2 | Delta-6 desaturase for LC-PUFA synthesis | Key for arachidonic acid and DHA production |
| ELOVL2 | Elongase for LC-PUFA synthesis | Involved in DHA biosynthesis |
| ELOVL5 | Elongase for LC-PUFA synthesis | Determines LC-PUFA profiles |
| CD36 | Fatty acid transporter | Mediates LCFA uptake in heart and muscle |
| FABP3 | Cytosolic fatty acid binding protein | Facilitates intracellular LCFA trafficking |
| DGAT1 | Diacylglycerol acyltransferase | Catalyzes final step of triglyceride synthesis |
| DGAT2 | Diacylglycerol acyltransferase | Important for lipid droplet formation |
| PPARA | Nuclear receptor activated by LCFAs | Master regulator of fatty acid oxidation genes |
| SIRT1 | Deacetylase regulating mitochondrial function | Suppression alters LCFA metabolism in cancer |
How Is long-chain fatty acid metabolic process Regulated?
Long-chain fatty acid metabolic process is regulated at multiple levels. Acutely, CPT1A is inhibited by malonyl-CoA, which is produced by acetyl-CoA carboxylase (ACC) in response to glucose and insulin, thereby preventing simultaneous fatty acid synthesis and oxidation. Hormones such as glucagon and adrenaline stimulate lipolysis and fatty acid oxidation, whereas insulin promotes storage. Transcriptionally, the nuclear receptor PPARA is activated by LCFAs and upregulates genes involved in uptake, activation, and beta-oxidation. SIRT1 deacetylates and modulates mitochondrial enzymes, and its suppression in hepatocellular carcinoma reprograms fatty acid metabolism toward increased fission and proliferation. Additionally, mitochondrial dynamics, particularly fission, influence the capacity for LCFA oxidation.
long-chain fatty acid metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CPT2 | CPT2 deficiency with rhabdomyolysis | Knockout or point-mutation in muscle cells |
| ACADVL | VLCAD deficiency | Knockout in hepatocytes or cardiomyocytes |
| HADHA | Mitochondrial trifunctional protein deficiency | Knock-in of patient mutations in iPSC-derived cardiomyocytes |
| SIRT1 | Hepatocellular carcinoma metabolic reprogramming | Knockout or overexpression in liver cancer cell lines |
| FADS2 | Altered LC-PUFA synthesis in inflammation | Knockout in immune or neuronal cells |
Cardiac Disease and Heart Failure
The heart relies heavily on long-chain fatty acid oxidation for ATP production, and impaired LCFA metabolism is a hallmark of heart failure and diabetic cardiomyopathy. Defects in CPT1A, CPT2, or the trifunctional protein cause cardiomyopathy and arrhythmias. Targeting LCFA oxidation is a therapeutic strategy in ischemic heart disease and heart failure.
Metabolic Disorders and Lipotoxicity
Excessive long-chain fatty acid supply without adequate storage or oxidation leads to lipotoxicity, contributing to insulin resistance, type 2 diabetes, and non-alcoholic fatty liver disease [1, 4]. Triglyceride synthesis via DGAT enzymes protects against lipotoxicity, and its failure exacerbates tissue damage. Triheptanoin, a medium-chain triglyceride, is approved for long-chain fatty acid oxidation disorders to bypass the defect.
Cancer Metabolism
Cancer cells reprogram long-chain fatty acid metabolism to support proliferation and survival. In hepatocellular carcinoma, increased mitochondrial fission drives reprogramming of fatty acid metabolism through suppression of SIRT1, promoting tumor growth. Targeting LCFA oxidation or desaturation is an emerging anticancer strategy.
Neurodegeneration and Inborn Errors
Defects in long-chain fatty acid oxidation cause severe neurological and muscular symptoms, including hypoglycemia, rhabdomyolysis, and neuropathy. In the brain, long-chain polyunsaturated fatty acids such as DHA are essential for membrane function, and their biosynthetic pathway is linked to neurodevelopment.
From long-chain fatty acid metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ACSL1 reduce LCFA oxidation? | ACSL1 knockout cell line |
| Does a patient CPT2 mutation impair mitochondrial import? | CPT2 point-mutation knock-in |
| Can overexpression of SCD1 protect from lipotoxicity? | SCD1 overexpression cell model |
| How does PPARA activation affect LCFA gene expression? | PPARA knockout and agonist treatment |
| Does tagging of HADHA reveal its subcellular localization? | HADHA knock-in with fluorescent tag |
| Which genes are essential for LCFA metabolism? | Genome-wide CRISPR knockout library screening |
How to Study the long-chain fatty acid metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Seahorse assay | Oxygen consumption rate | Real-time LCFA oxidation in cells |
| Radiolabeled palmitate oxidation | 14CO2 production | Beta-oxidation flux |
| LC-MS lipidomics | Lipid species abundance | Profiling LCFA and acyl-CoA pools |
| RNA-seq | Gene expression changes | Transcriptional response to LCFA |
| CRISPR knockout screen | Gene essentiality | Identifying novel LCFA regulators |
| Western blot | Protein expression and modification | Enzyme levels and acetylation |
| Confocal microscopy | Lipid droplet and mitochondrial morphology | Lipotoxicity and fission studies [4, 7] |
| qPCR | mRNA levels of target genes | Validation of metabolic gene expression |
Metabolic Flux Analysis
Seahorse extracellular flux analysis and radiolabeled fatty acid oxidation assays measure the rate of LCFA oxidation in live cells. These methods quantify oxygen consumption and CO2 production from labeled palmitate, providing functional readouts of GO:0001676 activity.
Lipidomics and Mass Spectrometry
LC-MS-based lipidomics profiles the abundance of long-chain fatty acids, acyl-CoAs, and complex lipids, revealing pathway intermediates and storage lipids. This approach is essential for detecting changes in desaturation and elongation.
Transcriptomics and CRISPR Screening
RNA-seq identifies transcriptional changes in LCFA metabolic genes, while CRISPR knockout screens systematically test gene essentiality. These methods link genotype to metabolic phenotype in high throughput.
Imaging and Mitochondrial Dynamics
Fluorescence microscopy of lipid droplets and mitochondrial networks assesses storage and fission/fusion events that regulate LCFA metabolism [4, 7]. Live-cell imaging with tagged proteins can track enzyme localization.
How CRISPR Can Be Used to Study GO:0001676 long-chain fatty acid metabolic process
Knockout
CRISPR knockout of genes such as ACSL1, CPT1A, or ACADVL abolishes specific steps in long-chain fatty acid metabolism, allowing researchers to test their contribution to oxidation, storage, and cell survival. Knockout cell models are widely used to validate metabolic dependencies in cancer and metabolic disease.
Point Mutation
Point mutations can mimic patient-derived missense variants in genes like CPT2 or HADHA, enabling precise structure-function studies of LCFA metabolic enzymes. These models help distinguish pathogenic mutations from benign polymorphisms.
Knock-in
Knock-in of fluorescent or affinity tags into endogenous loci such as HADHA or ACADVL allows real-time tracking of enzyme localization and interactions without overexpression artifacts. Knock-in of disease mutations in iPSCs provides isogenic models for cardiomyopathy.
Overexpression
Overexpression of SCD1, DGAT1, or FADS2 can drive lipid storage or desaturation, testing whether increased flux protects against lipotoxicity or promotes tumor growth [4, 8]. Overexpression models complement loss-of-function studies to establish causality.
How EDITGENE Supports long-chain fatty acid metabolic process Research
Researchers studying long-chain fatty acid metabolic process-related genes often need to determine whether a candidate gene is causally involved in oxidation, storage, or signaling. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for long-chain fatty acid metabolic process research.
Frequently Asked Questions About long-chain fatty acid metabolic process
What is long-chain fatty acid metabolic process?
It is the set of biochemical reactions and pathways involving fatty acids with 13 to 22 carbon atoms, including activation, mitochondrial import, beta-oxidation, desaturation, elongation, and storage [1, 5].
What genes are involved in long-chain fatty acid metabolic process?
Key genes include ACSL1, CPT1A, CPT2, ACADVL, HADHA, HADHB, SCD1, FADS1, FADS2, ELOVL2, ELOVL5, CD36, DGAT1, DGAT2, and PPARA [1, 2, 5, 8].
Why is long-chain fatty acid metabolism important for the heart?
The heart derives most of its ATP from long-chain fatty acid oxidation, and defects in this pathway cause cardiomyopathy and heart failure.
How is long-chain fatty acid oxidation regulated?
It is regulated by malonyl-CoA inhibition of CPT1A, hormonal signals, and transcription factors such as PPARA, as well as by SIRT1 and mitochondrial dynamics [1, 7].
What diseases are linked to defects in long-chain fatty acid metabolism?
Diseases include cardiomyopathy, CPT2 deficiency, VLCAD deficiency, insulin resistance, non-alcoholic fatty liver disease, and cancer [2, 4, 7].
What is the role of CPT1A in long-chain fatty acid metabolism?
CPT1A is the rate-limiting enzyme that transports long-chain acyl-CoA into mitochondria for beta-oxidation.
How can CRISPR be used to study long-chain fatty acid metabolism?
CRISPR knockout, knock-in, point mutation, and overexpression models allow causal testing of genes involved in LCFA oxidation, storage, and signaling.
What is lipotoxicity in the context of long-chain fatty acids?
Lipotoxicity is cell damage caused by excess long-chain fatty acids that cannot be stored or oxidized, and triglyceride synthesis protects against it.
Which experimental methods measure long-chain fatty acid oxidation?
Seahorse assays, radiolabeled palmitate oxidation, and LC-MS lipidomics are commonly used to measure LCFA oxidation and lipid profiles [2, 5].
What is the GO ID for long-chain fatty acid metabolic process?
The Gene Ontology ID is GO:0001676, under the biological_process ontology.
Conclusion
GO:0001676, long-chain fatty acid metabolic process, is a central biological pathway that governs energy production, membrane lipid synthesis, and signaling. Its dysregulation underlies cardiac disease, metabolic disorders, and cancer, making it a high-priority research area [1, 2, 7]. Understanding the genes and regulatory mechanisms involved requires robust experimental models. CRISPR-based knockout, point-mutation, knock-in, and overexpression cell models, combined with metabolic and lipidomic assays, provide the tools needed to dissect this pathway and identify therapeutic targets.
References
- 1. Nakamura MT et al.. 2014. Regulation of energy metabolism by long-chain fatty acids.. Prog Lipid Res 53:124-44 PMID: 24362249
- 2. Lopaschuk GD et al.. 2010. Myocardial fatty acid metabolism in health and disease.. Physiol Rev 90(1):207-58 PMID: 20086077
- 3. Schönfeld P et al.. 2016. Short- and medium-chain fatty acids in energy metabolism: the cellular perspective.. J Lipid Res 57(6):943-54 PMID: 27080715
- 4. Listenberger LL et al.. 2003. Triglyceride accumulation protects against fatty acid-induced lipotoxicity.. Proc Natl Acad Sci U S A 100(6):3077-82 PMID: 12629214
- 5. He Q et al.. 2023. Cellular Uptake, Metabolism and Sensing of Long-Chain Fatty Acids.. Front Biosci (Landmark Ed) 28(1):10 PMID: 36722264
- 6. Shirley M. 2020. Triheptanoin: First Approval.. Drugs 80(15):1595-1600 PMID: 32897506
- 7. Wu D et al.. 2022. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1.. Cancer Commun (Lond) 42(1):37-55 PMID: 34981667
- 8. Brenna JT et al.. 2022. New understandings of the pathway of long-chain polyunsaturated fatty acid biosynthesis.. Curr Opin Clin Nutr Metab Care 25(2):60-66 PMID: 34937850
